Purchase Order N3239824P0034
Award Date
9/29/24
Potential Completion Date
9/28/27
Potential Value
$153K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies, including...
This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command to Illumina, Inc. to provide a MiSeq DNA Sequencer for $111,782.23. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided various sequencing systems, reagents, and services to support research and diagnostics across multiple federal agencies. This award is likely part of Illumina's...
This firm fixed-price delivery order was awarded by the Southeast Area of the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $95,931 award is for the provision of an Illumina MiSeq System, a high-throughput DNA sequencing platform, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This delivery order is part of a...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the delivery of a MiSeq System sequencer. The award does not have a set-aside designation and has a ceiling value of $95,931. Illumina has a history of providing sequencing systems and related products and services to...